# Prosperity Bancshares Inc: overview

PB · NYSE · CIK 1068851 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pb.md) · [Financials](/companies/pb/financials.md) · [Filings](/companies/pb/filings.md) · [Insiders](/companies/pb/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.34](/filings/0001193125-25-270362.md) | not reported | [1.37](/filings/0001193125-26-215187.md) | [1.42](/filings/0001193125-26-338254.md) | [1.45](/filings/0001193125-25-270362.md) | not reported | [1.16](/filings/0001193125-26-215187.md) | [1.67](/filings/0001193125-26-338254.md) |
| Free cash flow | $m | [270 d](/filings/0001193125-25-270362.md) | [(211) d](/filings/0001193125-26-077437.md) | [171](/filings/0001193125-26-215187.md) | [91.8 d](/filings/0001193125-26-338254.md) | [186 d](/filings/0001193125-25-270362.md) | [68.5 d](/filings/0001193125-26-077437.md) | [178](/filings/0001193125-26-215187.md) | [158 d](/filings/0001193125-26-338254.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [5.05](/filings/0001193125-26-077437.md) | [5.73](/filings/0000950170-25-029222.md) | [4.51](/filings/0001193125-26-077437.md) | [5.05](/filings/0001193125-26-077437.md) | [5.72](/filings/0001193125-26-077437.md) |
| Free cash flow | $m | [676](/filings/0000950170-24-022171.md) | [464](/filings/0000950170-25-029222.md) | [612](/filings/0001193125-26-077437.md) | [452](/filings/0001193125-26-077437.md) | [517](/filings/0001193125-26-077437.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pb/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Holmes Ned S](/insiders/1136856.md) | Director | Sale (S) | 100 | $68.2425 | $6.8k | [Form 4](/filings/0001193125-26-428524.md) |
| 2026-10-21 | [Holmes Ned S](/insiders/1136856.md) | Director | Sale (S) | 500 | $68.2434 | $34.1k | [Form 4](/filings/0001193125-26-428524.md) |
| 2026-10-21 | [Holmes Ned S](/insiders/1136856.md) | Director | Sale (S) | 500 | $68.2516 | $34.1k | [Form 4](/filings/0001193125-26-428524.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $746.8m | 10,225,601 |  | Added +858,329 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $460.4m | 6,304,696 |  | Reduced −18,448 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $453.4m | 6,208,490 |  | Added +609,688 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $402.5m | 5,466,720 |  | Added +375,242 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $370.3m | 5,070,242 |  | Added +140,933 |
| [BARROW HANLEY MEWHINNEY & STRAUSS LLC](/funds/313028.md) | 2026-06-30 | $350.1m | 4,793,908 |  | Reduced −143,120 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $323.2m | 4,425,184 |  | Added +77,190 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $236.1m | 3,232,897 |  | Added +6,570 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $211.8m | 2,900,025 |  | Reduced −160,017 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $170.5m | 2,314,597 |  | Reduced −25,835 |

## Recent filings

[All 1,133 filings](/companies/pb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 06:30 ET | [8-K](/filings/0001193125-26-435040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-435040 |
| 2026-08-31 | 16:30 ET | [8-K/A](/filings/0001193125-26-376886.md) | 9.01 Financial statements and exhibits | 0001193125-26-376886 |
| 2026-08-06 | 16:33 ET | [10-Q](/filings/0001193125-26-338254.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338254 |
| 2026-07-29 | 06:30 ET | [8-K](/filings/0001193125-26-322053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-322053 |
| 2026-07-01 | 07:15 ET | [8-K](/filings/0001193125-26-291486.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-291486 |
| 2026-05-11 | 18:42 ET | [10-Q](/filings/0001193125-26-215187.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215187 |
| 2026-04-29 | 06:30 ET | [8-K](/filings/0001193125-26-188851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-188851 |
| 2026-04-23 | 07:30 ET | [8-K](/filings/0001193125-26-171838.md) | 5.07 Shareholder vote results | 0001193125-26-171838 |
| 2026-04-22 | 08:05 ET | [8-K](/filings/0001193125-26-168540.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-168540 |
| 2026-03-16 | 07:00 ET | [DEF 14A](/filings/0001193125-26-107142.md) | Proxy statement, period 2026-03-11 | 0001193125-26-107142 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-077437.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1068851
- Tickers: PB
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: TX
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 06:31 ET. No prices; not investment advice.